<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>More than 3 million patients around the world have received <z:chebi fb="0" ids="37941">clopidogrel</z:chebi>, an inhibitor of platelet aggregation, which has largely replaced <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> in clinical practice as it was believed to be devoid of the side effects caused by <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>We herein report the case of a woman who developed <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) after 1 year of treatment with <z:chebi fb="0" ids="37941">clopidogrel</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The absence of other plausible causes suggests that her <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was induced by <z:chebi fb="0" ids="37941">clopidogrel</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Although this is a very rare case, clinicians should be alert to the possibility of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> associated with <z:chebi fb="0" ids="37941">clopidogrel</z:chebi> use </plain></SENT>
</text></document>